327 related articles for article (PubMed ID: 21376640)
1. A molecular basis for NKT cell recognition of CD1d-self-antigen.
Mallevaey T; Clarke AJ; Scott-Browne JP; Young MH; Roisman LC; Pellicci DG; Patel O; Vivian JP; Matsuda JL; McCluskey J; Godfrey DI; Marrack P; Rossjohn J; Gapin L
Immunity; 2011 Mar; 34(3):315-26. PubMed ID: 21376640
[TBL] [Abstract][Full Text] [Related]
2. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex.
Wun KS; Ross F; Patel O; Besra GS; Porcelli SA; Richardson SK; Keshipeddy S; Howell AR; Godfrey DI; Rossjohn J
J Biol Chem; 2012 Nov; 287(46):39139-48. PubMed ID: 22995911
[TBL] [Abstract][Full Text] [Related]
3. Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.
Patel O; Pellicci DG; Uldrich AP; Sullivan LC; Bhati M; McKnight M; Richardson SK; Howell AR; Mallevaey T; Zhang J; Bedel R; Besra GS; Brooks AG; Kjer-Nielsen L; McCluskey J; Porcelli SA; Gapin L; Rossjohn J; Godfrey DI
Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19007-12. PubMed ID: 22065767
[TBL] [Abstract][Full Text] [Related]
4. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E; Mattner J
Front Immunol; 2019; 10():1449. PubMed ID: 31293596
[TBL] [Abstract][Full Text] [Related]
5. A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells.
Wun KS; Cameron G; Patel O; Pang SS; Pellicci DG; Sullivan LC; Keshipeddy S; Young MH; Uldrich AP; Thakur MS; Richardson SK; Howell AR; Illarionov PA; Brooks AG; Besra GS; McCluskey J; Gapin L; Porcelli SA; Godfrey DI; Rossjohn J
Immunity; 2011 Mar; 34(3):327-39. PubMed ID: 21376639
[TBL] [Abstract][Full Text] [Related]
6. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
Le Nours J; Praveena T; Pellicci DG; Gherardin NA; Ross FJ; Lim RT; Besra GS; Keshipeddy S; Richardson SK; Howell AR; Gras S; Godfrey DI; Rossjohn J; Uldrich AP
Nat Commun; 2016 Feb; 7():10570. PubMed ID: 26875526
[TBL] [Abstract][Full Text] [Related]
7. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
Pellicci DG; Patel O; Kjer-Nielsen L; Pang SS; Sullivan LC; Kyparissoudis K; Brooks AG; Reid HH; Gras S; Lucet IS; Koh R; Smyth MJ; Mallevaey T; Matsuda JL; Gapin L; McCluskey J; Godfrey DI; Rossjohn J
Immunity; 2009 Jul; 31(1):47-59. PubMed ID: 19592275
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
[TBL] [Abstract][Full Text] [Related]
9. NKT TCR recognition of CD1d-α-C-galactosylceramide.
Patel O; Cameron G; Pellicci DG; Liu Z; Byun HS; Beddoe T; McCluskey J; Franck RW; Castaño AR; Harrak Y; Llebaria A; Bittman R; Porcelli SA; Godfrey DI; Rossjohn J
J Immunol; 2011 Nov; 187(9):4705-13. PubMed ID: 21964029
[TBL] [Abstract][Full Text] [Related]
10. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
[TBL] [Abstract][Full Text] [Related]
11. Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors.
Guo T; Chamoto K; Nakatsugawa M; Ochi T; Yamashita Y; Anczurowski M; Butler MO; Hirano N
PLoS One; 2016; 11(5):e0156114. PubMed ID: 27213277
[TBL] [Abstract][Full Text] [Related]
12. Recognition of CD1d-restricted antigens by natural killer T cells.
Rossjohn J; Pellicci DG; Patel O; Gapin L; Godfrey DI
Nat Rev Immunol; 2012 Dec; 12(12):845-57. PubMed ID: 23154222
[TBL] [Abstract][Full Text] [Related]
13. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
[TBL] [Abstract][Full Text] [Related]
14. Antigen Specificity of Type I NKT Cells Is Governed by TCR β-Chain Diversity.
Cameron G; Pellicci DG; Uldrich AP; Besra GS; Illarionov P; Williams SJ; La Gruta NL; Rossjohn J; Godfrey DI
J Immunol; 2015 Nov; 195(10):4604-14. PubMed ID: 26423148
[TBL] [Abstract][Full Text] [Related]
15. CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptors.
Chamoto K; Guo T; Imataki O; Tanaka M; Nakatsugawa M; Ochi T; Yamashita Y; Saito AM; Saito TI; Butler MO; Hirano N
J Autoimmun; 2016 Apr; 68():39-51. PubMed ID: 26748722
[TBL] [Abstract][Full Text] [Related]
16. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors.
Pellicci DG; Clarke AJ; Patel O; Mallevaey T; Beddoe T; Le Nours J; Uldrich AP; McCluskey J; Besra GS; Porcelli SA; Gapin L; Godfrey DI; Rossjohn J
Nat Immunol; 2011 Jul; 12(9):827-33. PubMed ID: 21804559
[TBL] [Abstract][Full Text] [Related]
17. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
[TBL] [Abstract][Full Text] [Related]
18. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.
Arrenberg P; Halder R; Dai Y; Maricic I; Kumar V
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10984-9. PubMed ID: 20534460
[TBL] [Abstract][Full Text] [Related]
19. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
20. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
Lawson V
Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]